Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema
NCT00000115 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2009-09-17
Summary
To test the efficacy of acetazolamide for the treatment of uveitis-associated cystoid macular edema.
Conditions
- Macular Edema, Cystoid
Interventions
- DRUG
-
Acetazolamide
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 8 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1990-12-31
- Completion
- 1994-06-30
More Related Trials
-
Evaluation and Treatment of Patients With Inflammatory Eye Diseases
NCT00006188 ·Status: COMPLETED
-
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
NCT00331331 ·Status: COMPLETED
-
Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate
NCT00349739 ·Status: NO_LONGER_AVAILABLE
-
Safety and Efficacy of AIN457 in Patients With Quiescent Non-infectious Uveitis
NCT01032915 ·Status: TERMINATED ·Phase: PHASE3
-
Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
NCT00615693 ·Status: COMPLETED ·Phase: PHASE2
-
Topical Interferon Gamma for Macular Edema Secondary to Uveitis
NCT01376362 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis
NCT00070759 ·Status: COMPLETED ·Phase: PHASE2
-
Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis
NCT00043667 ·Status: COMPLETED ·Phase: PHASE2
-
An Evaluation of Safety and Efficacy of Anecortave Acetate Versus Placebo in Patients With Subfoveal CNV Due to Exudative AMD
NCT00058994 ·Status: COMPLETED ·Phase: PHASE3
-
Incidence of Macular Edema in a Uveitis Population
NCT06686641 ·Status: ACTIVE_NOT_RECRUITING
-
Treatment of Chronic Central Serous Chorioretinopathy With Open-Label Anecortave Acetate
NCT00489840 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Intravitreal Celecoxib for Chronic Uveitis
NCT02131012 ·Status: TERMINATED ·Phase: PHASE1
-
Conbercept in Choroidal Neovascularization Secondary to Uveitis
NCT02934841 ·Status: UNKNOWN ·Phase: PHASE2
-
Treatment FOr Corticosteroid Dependent UveitiS
NCT06258915 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Pilot Study of Ranibizumab (Lucentis) for Uveitic Cystoid Macular Edema
NCT00826618 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Eye Tissue
NCT00001224 ·Status: COMPLETED
-
ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study)
NCT02931175 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implant vs Standardized Therapy
NCT00468871 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Daclizumab and Sirolimus to Treat Uveitis
NCT00078689 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of Adalimumab in Patients With Active Uveitis
NCT01138657 ·Status: COMPLETED ·Phase: PHASE3
-
Acute Pseudophakic Cystoid Macular Edema Treatment Trial: Intravitreal Ranibizumab Versus Triamcinolone Acetonide
NCT02294656 ·Status: COMPLETED ·Phase: PHASE1
-
Leflunomide to Treat Uveitis
NCT00001863 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study for the Evaluation of Intravitreal Infliximab in the Treatment of Uveitic Macular Edema
NCT00958906 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Screening for NEI Clinical Studies
NCT00001734 ·Status: COMPLETED
-
Phase 2 Study of MM-093 to Treat Patients With Uveitis
NCT00444743 ·Status: COMPLETED ·Phase: PHASE2